title: Fluorodeoxyglucose positron emission tomography/magnetic resonance imaging: current status, future aspects.
abstract: Simultaneous positron emission tomography (PET)/magnetic resonance (MR) imaging is a promising novel technology for oncology diagnosis and staging and neurologic and cardiac applications. Our institution's current research protocol results in a total imaging time of approximately 45 to 70 minutes with simultaneous PET/MR imaging, making this a feasible total body imaging protocol. Further development of MR-based attenuation correction will improve PET quantification. Quantitatively accurate multiparametric PET/MR data sets will likely improve diagnosis of disease and help guide and monitor the therapies for individualized patient care.
authors.affiliation: Department of Nuclear Medicine/Radiology, Royal University Hospital, Saskatoon, Saskatchewan, Canada. Electronic address: rajan.rakheja@gmail.com.
authors.forename: Rajan
authors.initials: R
authors.lastname: Rakheja
authors.affiliation: Department of Radiology, New York University School of Medicine, 550 First Avenue, New York, NY, USA.
authors.forename: Hersh
authors.initials: H
authors.lastname: Chandarana
authors.affiliation: Department of Radiology, New York University School of Medicine, 550 First Avenue, New York, NY, USA.
authors.forename: Fabio
authors.initials: F
authors.lastname: Ponzo
authors.affiliation: Department of Radiology, New York University School of Medicine, 550 First Avenue, New York, NY, USA.
authors.forename: Alexandra L
authors.initials: AL
authors.lastname: Seltzer
authors.affiliation: Department of Radiology, New York University School of Medicine, 550 First Avenue, New York, NY, USA.
authors.forename: Luis S
authors.initials: LS
authors.lastname: Beltran
authors.affiliation: MR R&D Collaborations, Siemens Healthcare, New York, NY, USA.
authors.forename: Christian
authors.initials: C
authors.lastname: Geppert
authors.affiliation: Department of Radiology, New York University School of Medicine, 550 First Avenue, New York, NY, USA.
authors.forename: Kent P
authors.initials: KP
authors.lastname: Friedman
mesh_terms: D004867:Equipment Design / Q000639:trends; D019788:Fluorodeoxyglucose F18; D005544:Forecasting; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000295:instrumentation / Q000639:trends*; D064847:Multimodal Imaging / Q000295:instrumentation / Q000639:trends*; D009369:Neoplasms / Q000175:diagnosis; D009422:Nervous System Diseases / Q000175:diagnosis; D049268:Positron-Emission Tomography / Q000295:instrumentation / Q000639:trends*; D011832:Radiation Injuries / Q000209:etiology; D019275:Radiopharmaceuticals; D011880:Radiotherapy Planning, Computer-Assisted; D012307:Risk Factors
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
keywords: Apparent diffusion coefficient; Bone metastases; Dementia; Lung cancer; Magnetic resonance; Positron emission tomography; Sodium fluoride